Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes

Fahim Abbasi, Sang Ah Chang, James W. Chu, Theodore P. Ciaraldi, Cindy Lamendola, Tracey McLaughlin, Gerald M. Reaven, Peter D. Reaven

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes'. Together they form a unique fingerprint.

Medicine & Life Sciences